Iridex Corporation

IPO

Advancing laser therapies for ophthalmology

Public · Mountain View, United States · Founded 1989 · $10.0M raised

Employees
51–200
Founded
1989
Business Model
B2B
Website
iridex.com
Total Funding
$10.0M
Last Round
$4.0M Convertible NoteMar 2025
Rounds
2
Type
Public

About

IRIDEX Corporation is a publicly traded (Nasdaq: IRIX) medical device company headquartered in Mountain View, California. Founded in 1989, the company is a worldwide leader in developing, manufacturing, and marketing innovative laser-based medical systems, delivery devices, and single-use consumables for the treatment of retinal diseases and glaucoma. Its product lines include the IQ 532, IQ 810, and IQ 577 laser systems powered by proprietary MicroPulse technology, which enables repeatable, tissue-sparing therapies. IRIDEX products are sold through a global network of distributors and direct sales teams.

Summary

Iridex Corporation is a Healthcare company based in Mountain View, United States, founded in 1989. It has raised $10.0M in total across 2 rounds, most recently a $4.0M Convertible Note round in Mar 2025.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

ConvertibleConvertible NoteMar 2025
$4.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Similar Companies